MA 02.05 Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)

This article has no abstract
Epistemonikos ID: e877994d14179f65f252bf06c9a7b0308d0009e1
First added on: Feb 12, 2025